|
|
|
| Effect of Anlotinib Combined with Camrelizumab in the Treatment of Driver Gene Negative Advanced NSCLC with Failed Standard Chemotherapy |
| WU Chunmei, FENG Yulai |
| First-author's address: Department of Pharmacy, Lianyungang Hospital of TCM, Lianyungang 222004, China |
|
|
|
|
|
|
Received: 21 November 2024
|
|
|
|
|
|
|
